Publications found:
512,290
Sort by:
The 2027-2032 World Outlook for Multiple Myeloma
US$ 1,195.00
This study covers the world outlook for multiple myeloma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Multiple Myeloma Treatments
US$ 1,195.00
This study covers the world outlook for multiple myeloma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Multiple Sclerosis Drugs
US$ 1,195.00
This study covers the world outlook for multiple sclerosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Multiplexed Diagnostics
US$ 1,195.00
This study covers the world outlook for multiplexed diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Muscle Relaxants
US$ 1,195.00
This study covers the world outlook for muscle relaxants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Musculoskeletal Diseases
US$ 1,195.00
This study covers the world outlook for musculoskeletal diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
288 pages
The 2027-2032 World Outlook for Musculoskeletal Disorders
US$ 1,195.00
This study covers the world outlook for musculoskeletal disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Myasthenia Gravis
US$ 1,195.00
This study covers the world outlook for myasthenia gravis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Myasthenia Gravis Drugs
US$ 1,195.00
This study covers the world outlook for myasthenia gravis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Myasthenia Gravis Treatments
US$ 1,195.00
This study covers the world outlook for myasthenia gravis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Myocardial Ischemia
US$ 1,195.00
This study covers the world outlook for myocardial ischemia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for N95 Masks
US$ 1,195.00
This study covers the world outlook for N95 masks across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...
January 2026
287 pages
The 2027-2032 World Outlook for Nanomedicines
US$ 1,195.00
This study covers the world outlook for nanomedicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
288 pages
The 2027-2032 World Outlook for Narcolepsy Drugs
US$ 1,195.00
This study covers the world outlook for narcolepsy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Drug Deliveries
US$ 1,195.00
This study covers the world outlook for nasal drug deliveries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Drug Delivery Devices
US$ 1,195.00
This study covers the world outlook for nasal drug delivery devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Drug Delivery Systems
US$ 1,195.00
This study covers the world outlook for nasal drug delivery systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Nasal High Flow
US$ 1,195.00
This study covers the world outlook for nasal high flow across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Polyps Treatments
US$ 1,195.00
This study covers the world outlook for nasal polyps treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Splints
US$ 1,195.00
This study covers the world outlook for nasal splints across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Sprays
US$ 1,195.00
This study covers the world outlook for nasal sprays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Native Collagen
US$ 1,195.00
This study covers the world outlook for native collagen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Natural Superdisintegrants
US$ 1,195.00
This study covers the world outlook for natural superdisintegrants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for NDDS for Cancer Therapies
US$ 1,195.00
This study covers the world outlook for NDDS for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for NDDS in Cancer Therapies
US$ 1,195.00
This study covers the world outlook for NDDS in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Nebulizer Devices
US$ 1,195.00
This study covers the world outlook for nebulizer devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Needle Biopsies
US$ 1,195.00
This study covers the world outlook for needle biopsies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Needle-Free Devices
US$ 1,195.00
This study covers the world outlook for needle-free devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Needle-Free Drug Deliveries
US$ 1,195.00
This study covers the world outlook for needle-free drug deliveries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Needle Guides
US$ 1,195.00
This study covers the world outlook for needle guides across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
